Transform Asian science into insights that resonate with global investors and pharmaceutical companies.
A matching platform that leads to meaningful, real-world dialogue.

iDCP analyzes research data, papers, and slides from biotech companies and academia using AI, and automatically transforms them into investment-ready materials for global VCs, CVCs, and pharmaceutical companies.
From preparation to connection, iDCP delivers your research to the global opportunity table seamlessly.

Free during our early access period

Download the iDCP Overview

A curated set of resources to support research and business development.

Download the Overview (Free)

pain

Researchers and science-driven startups commonly face the same challenge when pursuing overseas funding.
Startups often lack materials that meet the standards required by global VCs.
Academia, meanwhile, struggles to prepare even the minimum set of documents needed to generate external interest.
As a result, many promising research projects are unable to move forward to meaningful dialogue with international investors or pharmaceutical companies.

  • Not Ready for Investor Evaluation

    • English materials do not align with investor evaluation criteria
    • Required information for international standards (CMC / CTD / IND) is missing
    • Research value and risks are not clearly structured, preventing progress after initial meetings

  • Preparation Becomes a Bottleneck Before Any Feedback

    • Significant time is spent preparing pitch decks and English materials, slowing core research activities
    • It is difficult to determine what format overseas investors expect
    • NDA, COI, and export control preparation adds further delays to collaboration
Free during our early access period

What is iDCP?

A platform that connects Asian science with global investors and pharmaceutical companies through international standards, structured information, and smart matching.

Leveraging iPark’s scientific expertise and global network, iDCP transforms research content into formats that overseas VCs can evaluate.
With instant online NDA execution, projects move seamlessly from preparation to real investor dialogue.

functioin

iDCP uses AI to analyze research data, papers, and slides, automatically structuring them into investor-oriented information aligned with international evaluation criteria.

  • Structure(AI Structuring & Translation)

    Research data is automatically converted into internationally standardized formats, making it easy for VCs and pharmaceutical companies to evaluate.

  • Connect(NDA / CDA Execution)

    NDAs can be executed instantly online, enabling secure document sharing and smooth entry into initial discussions.

  • Communicate(Direct Business Dialogue)

    After NDA execution, users can immediately engage in chats and meetings with investors, accelerating external feedback.

value

By preparing materials that are truly ready for submission, projects are more likely to advance beyond initial meetings and be recognized as investable opportunities.

  • Cost Cut
    (Cost Reduction)

    Eliminate expenses related to overseas travel, exhibitions, and intermediaries.
    Access the right partners directly from the lab.

  • Time Saving
    (Time Creation)

    Reduce time spent on document preparation, translation, and adjustments.
    Refocus on research and business development.

  • Global Reach
    (Opportunity Maximization)

    Reduce time spent on document preparation, translation, and adjustments.
    Refocus on research and business development.

  • Security & Trust
    (Confidence and Protection)

    Built on iPark’s security standards and vetted network.
    Complete NDA execution in one place and move forward with trusted partners.

The shortest path to collaboration and fundraising.

Traditionally, the process often stops at “search → outreach → adjustment → confidentiality.”
With iDCP, everything from information structuring to NDA execution is unified in one platform.

Normal
Acquisition
Flow
~Making contacts
~NDA signing
• • •
Tie-up
Target list
creation
and
Selection
On-site
sales
activities
Appointing
and
information
disclosure
Following
up mail
Meeting
and
mail
Meeting
and
mail
Organizing
confidential
information
Disclosure
recipient
Management
Target list
creation
and
Selection
• • •
Partnership
Multiple sessions Time required to secure appointments
iDCP
Utilization Flow
~Making contacts
~NDA signing
• • •
Tie-up
Automatically
structuring
information and
making it pablic
Information of
interest can be
obtained instantly
Chat services
and online
meetings within PF
Chat services
and online
meetings within PF
For chat, easy
facilitation and
management
Chat services
and online
meetings within PF
• • •
Partnership
~Making contacts
~NDA signing
• • •
Tie-up
Normal
Acquisition
Flow
Target list
creation
and
Selection
On-site
sales
activities
Appointing
and
information
disclosure
Following
up mail
Meeting
and
mail
Meeting
and
mail
Organizing
confidential
information
Disclosure
recipient
Management
Target list
creation
and
Selection
• • •
Partnership
Multiple sessions Time required to secure appointments
iDCP
Utilization Flow
Automatically
structuring
information and
making it pablic
Information of
interest can be
obtained instantly
Chat services
and online
meetings within PF
Chat services
and online
meetings within PF
For chat, easy
facilitation and
management
Chat services
and online
meetings within PF
• • •
Partnership

detail

From AI structuring and recommendation to NDA execution and direct dialogue,
海 iDCP integrates all essential processes needed to connect with overseas VCs and pharmaceutical companies.

  • AI-Based Information Structuring

    Company and research information is automatically structured into formats that investors and pharmaceutical companies can easily understand.
    Content is converted into submission-ready information aligned with evaluation criteria.

  • AI Search & Matching Recommendations

    Based on research themes, strengths, and domains, AI recommends suitable investors and companies.
    Reach the right partners instantly — even from within the lab.

  • Simple NDA Execution

    Execute NDAs securely online.
    Begin safe information sharing and transition smoothly into initial discussions.

  • Seamless Matching Through Chat

    After NDA execution, communicate directly with investors and companies via chat.
    Obtain feedback quickly and significantly shorten the path to business discussions.

Free during our early access period

Operator

What is Shonan iPark?

Shonan Health Innovation Park (Shonan iPark) is Japan’s first pharmaceutical-initiated science park, established in 2018 through the opening of Takeda Pharmaceutical Company’s research center.
It brings together around 190 organizations and over 2,500 professionals across diverse life science–related fields.

Shonan iPark aims to create a place where industry, government, and academia collaborate to accelerate health innovation and enable social implementation.
With around 2,000 collaborations generated annually (FY2023), it supports the steady advancement of research and commercialization.

An environment where companies, VCs, and pharmaceutical partners connect and collaborate

  • 190+ organizations and 2,500+ professionals across life science fields
  • Around 2,000 collaborations generated annually
  • Strong industry–academia integration for rapid partnerships
  • A trusted platform bridging research and commercialization

Partners

Global partners supporting international research expansion.
We collaborate with leading incubation and innovation hubs worldwide to support the global expansion of research.

  • usaLabCentral

    LabCentral is a leading life science startup incubator based in Cambridge, Massachusetts, spanning Kendall Square and the Harvard University campus.
    It provides lab infrastructure, funding access, and strong connections with investors and pharmaceutical companies, supporting startups from inception through growth.

  • koreaKoreaBIO

    KoreaBIO represents South Korea’s biotech ecosystem, supporting collaboration among domestic companies, policy advocacy, and global expansion.
    With more than 670 member organizations, it bridges R&D, manufacturing, and commercialization.

  • 台湾National Biotechnology Research Park (NBRP)

    Located in Tainan, Taiwan, NBRP is a government-led life science research hub connecting foundational research to commercialization.
    It brings together public research institutions, startups, and international partners to support the growth of Asia’s biotech innovation ecosystem.

Prepare your research for global investors and pharmaceutical companies.

Experience iDCP hands-on and start shaping your research results
into materials that international VCs and pharmaceutical partners can evaluate.

Free during our early access period

faq

What types of organizations is iDCP designed for?

What types of organizations is iDCP designed for?

iDCP is primarily designed for biotech startups and academic institutions.
Any organization that wants to organize and share research data, papers, or slides in a format that global VCs and pharmaceutical companies can evaluate is welcome, regardless of size or industry.

How accurate is the AI-generated information?

We use the latest AI models, specialized in life sciences, to perform structuring and translation.
Users can review, add, and revise the content themselves, ensuring accuracy for highly specialized research.
Final adjustments are made by users to reflect their expertise.

How long does AI structuring and translation take?

After uploading your organization’s URL and input data files, AI structuring and translation are completed within minutes to tens of minutes.
You can then review, add, and edit the content as needed.

Can I leverage iPark’s network?

Yes. We activate iDCP by leveraging the science-focused community and expertise cultivated through iPark.
Based on research content and objectives, we help create meaningful connections and collaboration opportunities.

How are security and confidentiality handled?

All data is encrypted and managed under strict access controls.
You can freely designate information as Confidential.
Confidential information will not be disclosed to other users unless an individual NDA is executed on iDCP.

Need Help?

Not sure how to prepare for overseas VC outreach?

If you’re struggling with preparation for international investors,
our expert team is here to support you with required materials and global standards compliance.

Contact